Back to search
Prurigo Nodularis (PN)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Prurigo Nodularis (PN) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Prurigo Nodularis (PN) trials you may qualify forThe purpose of this study is to evaluate effect of povorcitinib on itch and skin lesions in participants with prurigo nodularis.
Evaluate the efficacy and safety of ICP-332 in participants with Prurigo Nodularis (PN)
With the arrival of dupilumab as the first available targeted therapy for PN, there is an unmet need for real-world data and translational research on the worki…
The purpose of this study is to evaluate effect of povorcitinib on itch and skin lesions in participants with prurigo nodularis.
The purpose of this study is to assess the efficacy and safety of barzolvolimab in adults with prurigo nodularis.
The purpose of this study is to evaluate the safety and tolerability of Ruxolitinib cream in participants with Prurigo Nodularis (PN).